Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Operating Expenses | 1,553 | 2,319 | 1,681 | 1,508 | 856 |
| Operating Income | -1,553 | -2,319 | -1,681 | -1,508 | -856 |
| Other Income | 789 | 438 | 136 | 85 | 45 |
| Pre-tax Income | -764 | -1,881 | -1,545 | -1,423 | -811 |
| Net Income Continuous | -764 | -1,881 | -1,545 | -1,423 | -811 |
| Net Income | $-764 | $-1,881 | $-1,545 | $-1,423 | $-811 |
| EPS Basic Total Ops | -0.04 | -0.09 | -0.07 | 0.47 | -0.04 |
| EPS Basic Continuous Ops | -0.04 | -0.09 | -0.07 | 0.47 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.09 | -0.07 | 0.47 | -0.04 |
| EPS Diluted Continuous Ops | -0.04 | -0.09 | -0.07 | 0.47 | -0.04 |
| EBITDA(a) | $-1,553 | $-2,319 | $-1,681 | $-1,508 | $-856 |